Edward W. Zhou, PharmD, is a Post-Doctoral Fellow at the Center for Integration of Science and Industry at Bentley University. He received his Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences, Boston, MA. He obtained a certificate from the MIT xPRO Drug and Medical Device Development Program. During his predoctoral internship, Edward worked with Pfizer Global Regulatory Affairs in organizing internal and public information databases for the pending FDA Oncologic Drugs Advisory Committee review. During his Newton-Wellesley Hospital rotation, Edward created adjustable python code packages for interpreting health outcome metrics from EPIC metadata. He has co-authored several peer-reviewed publications at Brigham and Women’s Hospital, Harvard Medical School, which focus on the identification of drug targets and novel pharmacotherapeutics for neurological disorders. Starting at Bentley University in February 2021, his current research projects include the integration of research algorithms into existing database frameworks and the improvement of search field functionality and accuracy to expand the scope of future research projects.
Edward W. Zhou
By this expert
Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis
The empirical analysis of public sector investments and the health value created by the drugs selected for Medicare price negotiations provides a cost basis for the assessment of the maximum fair price.